Alkermes Plc (ALKS)

46.02
NASDAQ : Health Technology
Prev Close 46.15
Day Low/High 45.40 / 46.95
52 Wk Low/High 41.15 / 71.22
Avg Volume 1.25M
Exchange NASDAQ
Shares Outstanding 155.00M
Market Cap 7.15B
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Unreasonable Earnings Expectations?: Cramer's 'Mad Money' Recap (Monday 4/16/18)

Unreasonable Earnings Expectations?: Cramer's 'Mad Money' Recap (Monday 4/16/18)

Washington receded and earnings came to the fore, but we're still seeing insane values and some surprises, says Jim Cramer.

Alkermes Wins Quick Reversal From FDA on Antidepressant Drug

Alkermes Wins Quick Reversal From FDA on Antidepressant Drug

Two weeks ago, the agency told Alkermes it needed more trials for antidepressant drug candidate ALKS-5461. The agency, however, had a change of heart, sending shares jumping on the news.

American Medical Association Rejects Idea of Time Limits on Opioid Scripts

American Medical Association Rejects Idea of Time Limits on Opioid Scripts

While more than half the states in the U.S. have passed time limits on opioid prescription as a way to battle the epidemic, the AMA says that should be left up to the doctor and patient.

Two to Buy on the Dip

Two to Buy on the Dip

Talk of intensifying trade war is creating some bargains for investors.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Alkermes Plc

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Alkermes Plc

Levi & Korsinsky announces it has commenced an investigation of Alkermes plc ("Alkermes" or "the Company") (NASDAQGS:ALKS) concerning possible violations of federal securities laws.

Dow Comes Off Session Lows, Finishes Day Down More Than 400 Points

Dow Comes Off Session Lows, Finishes Day Down More Than 400 Points

Stocks finish down sharply on Monday, the first trading day of the second quarter, after China's Ministry of Finance announces new tariffs of up to 25% on certain U.S. products.

Alkermes Surprised, Angered by FDA Rejection of Antidepressant

Alkermes Surprised, Angered by FDA Rejection of Antidepressant

Alkermes says the rejection of antidepressant drug ALKS 5461 is a head-scratcher, and it's calling for a prompt meeting with the regulator to get to the bottom of the decision.

Trump's Opioid Plan Gives Alkerme's Vivitrol Drug a Sales Boost

Trump's Opioid Plan Gives Alkerme's Vivitrol Drug a Sales Boost

Alkermes has spent money lobbying and donating to elected officials, and in the White House opioid plan, it seems to have paid off, as opioid blocker Vivitrol becomes part of prison protocol.

ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alkermes Plc To Contact The Firm

ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alkermes Plc To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Alkermes plc ("Alkermes" or the "Company") (NASDAQ:ALKS) of the January 22, 2018 deadline to seek the role of lead plaintiff in a...

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of January 22 Deadline In Securities Class Action Against Alkermes Plc (ALKS)

Scott+Scott, Attorneys At Law, LLP Reminds Investors Of January 22 Deadline In Securities Class Action Against Alkermes Plc (ALKS)

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national securities and consumer rights litigation firm, reminds investors that a class action lawsuit is pending against Alkermes plc (NASDAQ: ALKS) ("Alkermes" or...

ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alkermes Plc To Contact The Firm

ALKERMES INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Alkermes Plc To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Alkermes plc ("Alkermes" or the "Company") (NASDAQ:ALKS) of the January 22, 2018 deadline to seek the role of lead plaintiff in a...

Alkermes Is Getting Ready for a Rally

Alkermes Is Getting Ready for a Rally

ALKS's choppy trading period may be coming to a close.

Alkermes: Cramer's Top Takeaways

Alkermes: Cramer's Top Takeaways

Richard Pops, chairman and CEO of Alkermes, tells Jim Cramer about the company's 2018 outlook for drug development.

Good News Matters in This Market: Cramer's 'Mad Money' Recap (Monday 1/8/18)

Good News Matters in This Market: Cramer's 'Mad Money' Recap (Monday 1/8/18)

From global growth and bonds to index funds, Jim Cramer explains why stocks keep going up, giving the Dow and Nasdaq their best start to the new year since 2006.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Alkermes Plc Of Class Action Lawsuit And Upcoming Deadline - ALKS

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Alkermes Plc Of Class Action Lawsuit And Upcoming Deadline - ALKS

Pomerantz LLP announces that a class action lawsuit has been filed against Alkermes plc ("Alkermes" or the "Company") (NASDAQ:ALKS) and certain of its officers.

The Klein Law Firm Reminds Investors Of A Class Action Commenced On Behalf Of Alkermes Plc Shareholders And A Lead Plaintiff Deadline Of January 22, 2018

The Klein Law Firm Reminds Investors Of A Class Action Commenced On Behalf Of Alkermes Plc Shareholders And A Lead Plaintiff Deadline Of January 22, 2018

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Alkermes plc (NASDAQ:ALKS) who purchased shares between February 24, 2015 and November 3, 2017.

ALKS SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Alkermes Plc And A Lead Plaintiff Deadline Of January 22, 2018

ALKS SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Alkermes Plc And A Lead Plaintiff Deadline Of January 22, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Alkermes plc...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Alkermes Plc Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 22, 2018

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Alkermes Plc Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 22, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Alkermes plc ("Alkermes") (NASDAQ: ALKS) between February 24,...

The Klein Law Firm Announces A Class Action Commenced On Behalf Of Alkermes Plc Shareholders And A Lead Plaintiff Deadline Of January 22, 2018

The Klein Law Firm Announces A Class Action Commenced On Behalf Of Alkermes Plc Shareholders And A Lead Plaintiff Deadline Of January 22, 2018

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Alkermes plc (NASDAQ: ALKS) who purchased shares between February 24, 2015 and November 3, 2017.

ALKS INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Alkermes Plc And A Lead Plaintiff Deadline Of January 22, 2018

ALKS INVESTOR ALERT: The Law Offices Of Vincent Wong Notifies Investors Of A Class Action Involving Alkermes Plc And A Lead Plaintiff Deadline Of January 22, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased Alkermes plc...

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alkermes Plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Alkermes Plc To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Alkermes Plc Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 22, 2018

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Alkermes Plc Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 22, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Alkermes plc ("Alkermes") (NASDAQ:ALKS) between February 24,...

Jobs Report Just Right for Stocks: Cramer's 'Mad Money' Recap (Friday 12/8/17)

Jobs Report Just Right for Stocks: Cramer's 'Mad Money' Recap (Friday 12/8/17)

Jim Cramer sees support in the jobs report, and has the game plan ready for next week, including the Fed and earnings.

TheStreet Quant Rating: C- (Hold)